International Clinical Trial: AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533175) titled 'AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight' on April 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Novo Nordisk A/S

Condition: Diabetes Mellitus Overweight Obesity

Intervention: Drug: NNC0487-0111

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: April 13, 2026

Target Sample Size: 630

Count...